All tenders
112351-2026
Suministro de medicamentos antineoplásicos Idecabtagén y Ciltacabtagén
ES111, European Union
Time Left to Bid
No deadline
OpenOtherFederal
Basic information
- Reference number
- 112351-2026
- Issuing organization
- N/A
- Government level
- Federal
- Solicitation type
- Other
- Title
- Suministro de medicamentos antineoplásicos Idecabtagén y Ciltacabtagén
- Source
- TED (EU)
- Source ID
- 112351-2026
Details
- Location
- ES111, European Union
Summary
Acuerdo marco para el suministro sucesivo de dos medicamentos antineoplásicos específicos (Idecabtagén Vicleucel y Ciltacabtagén Autoleucel) para los centros hospitalarios del Servicio Gallego de Salud. Contrato dividido en dos lotes, adjudicado a Bristol-Myers Squibb y Janssen-Cilag.
Framework agreement for successive supply of two specific antineoplastic medications for Galician Health Service hospital centers. Contract divided into two lots, awarded to Bristol-Myers Squibb and Janssen-Cilag.
Dates
- Publication
- 2026/02/17 12:00:00 AM UTC
- Closing date
- N/A
Estimated value
$99.5M EUR
How to bid
Classification
Normalized category
Other